Solid Biosciences Inc logo

Solid Biosciences Inc

NAS:SLDB (USA)  
$ 7.79 -0.02 (-0.26%) 10:08 PM EST
At Loss
P/B:
1.40
Market Cap:
$ 298.98M
Enterprise V:
$ 118.73M
Volume:
119.52K
Avg Vol (2M):
212.16K
Volume:
119.52K
At Loss
Avg Vol (2M):
212.16K

Business Description

Description
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
Name Current Vs Industry Vs History
Cash-To-Debt 7.98
Equity-to-Asset 0.85
Debt-to-Equity 0.12
Debt-to-EBITDA -0.27
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 12.72
9-Day RSI 23.06
14-Day RSI 30.02
6-1 Month Momentum % 215.47
12-1 Month Momentum % 45.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.94
Quick Ratio 14.94
Cash Ratio 14.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -53.3
Shareholder Yield % -38.22
Name Current Vs Industry Vs History
ROE % -54.43
ROA % -43.7
ROIC % -229.41
ROC (Joel Greenblatt) % -280.45
ROCE % -50.69

Financials (Next Earnings Date:2024-08-14 Est.)

SLDB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SLDB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Solid Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.94
Beta 3.02
Volatility % 147.33
14-Day RSI 30.02
14-Day ATR ($) 0.703953
20-Day SMA ($) 9.41
12-1 Month Momentum % 45.92
52-Week Range ($) 1.81 - 15.05
Shares Outstanding (Mil) 38.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Solid Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Solid Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Solid Biosciences Inc Frequently Asked Questions

What is Solid Biosciences Inc(SLDB)'s stock price today?
The current price of SLDB is $7.79. The 52 week high of SLDB is $15.05 and 52 week low is $1.81.
When is next earnings date of Solid Biosciences Inc(SLDB)?
The next earnings date of Solid Biosciences Inc(SLDB) is 2024-08-14 Est..
Does Solid Biosciences Inc(SLDB) pay dividends? If so, how much?
Solid Biosciences Inc(SLDB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1